Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: Implications for rational design of typhoid fever vaccines

Vaccine

Volumn 26, Issue 51, 2008, Pages 6639-6644

  Ruan, Ping ^a,b   Xia, Xiao Ping ^c   Sun, Dexter ^d   Ojcius, David M ^e   Mao, Ya Fei ^a,f   Yue, Wen Yan ^b   Yan, Jie ^a,f  

^a ZHEJIANG UNIVERSITY   (China)

^b SHAOXING UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d HOSPITAL FOR SPECIAL SURGERY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Immunoprotection; Prokaryotic expression; Salmonella paratyphi A; SpaO H1a; Superficial protein antigen

Indexed keywords

IMMUNOGLOBULIN G; PROTEIN H1A; PROTEIN SPAO; RECOMBINANT ANTIGEN; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SALMONELLA PARATYPHI; TYPHOID FEVER; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DNA, BACTERIAL; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PARATYPHOID FEVER; RECOMBINANT PROTEINS; SALMONELLA PARATYPHI A; SEQUENCE ANALYSIS, DNA; TYPHOID-PARATYPHOID VACCINES;

EID: 58149180183     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.030     Document Type: Article

References (39)

1. Engels E.A., Falagas M.E., Lau J., and Bennish M.L. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. BMJ 316 7125 (1998) 110-116
2. Panchanathan V., Kumar S., Yeap W., Devi S., Ismail R., Sarijan S., et al. Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole cell killed vaccine in Malaysian Air Force recruits. Bull World Health Org 79 9 (2001) 811-817
3. Begier E.M., Burwen D.R., Haber P., Ball R., Haber P, and and for the Vaccine Adverse Event Reporting System Working Groupa. Postmarketing safety surveillance for typhoid fever vaccines from the vaccine adverse event reporting system, July 1990 through June 2002. Clin Infect Dis 38 6 (2004) 771-779
4. Identification of Salmonella Species. Issue no: 1.1 Issue date: 03.05.05 Issued by Standards Unit, Evaluations and Standards Laboratory Specialist and Reference Microbiology Division.
5. Parry C.M., Hhien T.T., Dougan G., White N.J., and Farrar J.J. Typhoid fever. N Engl J Med 347 22 (2002) 1770-1782
6. Ciacci-Woolwine F., Blomfield I.C., Richardson S.H., and Mizel S.B. Salmonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line. Infect Immun 66 3 (1998) 1127-1134
7. Suarez M., and Rüssmann H. Molecular mechanisms of Salmonella invasion: the type III secretion system of the pathogenicity island I. Int Microbiol 1 3 (1998) 197-204
8. Muotiala A. Anti-IFN-γ-treated mice-a model for testing safety of live Salmonella vaccines. Vaccine 10 4 (1992) 243-246
9. Hueck C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62 2 (1998) 379-433
10. Li J., Ochman H., Groisman E.A., Boyd E.F., Salomon F., Nelson K., et al. Relationship between evolutionary rate and cellular location among the inv/spa invasion proteins of Salmonella enterica. Proc Natl Acad Sci USA 92 16 (1995) 7252-7256
11. Collazo C.M., and Galan J.E. Requirement for exported in secretion through the invasion-associated type III of Salmonella typhimurium. Infect Immun 64 9 (1996) 3524-3531
12. Kaniga K., Trollinger D., and Galan J.E. Identification of two targets of the Type III protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA Proteins. J Bacteriol 177 24 (1995) 7078-7085
13. Groisman E.A., and Ochman H. Cognate gene clusters govern invasion of host epithelial cells by Salmonella typhimurium and Shigella flexneri. EMBO J 12 10 (1993) 3779-3787
14. Gonzalez C.R. Lymphocytic proliferative response to outer membrane protein isolated from Samonella. Microbiol Immunol 37 10 (1993) 793-799
15. Korbsrisate S., Sarasombath S., Ekpo P., and Pongsunk S. Molecular cloning and expression of Salmonella paratyphi A 52 kDa specific protein gene. Asian Pac J Allergy Immunol 12 1 (1994) 27-37
16. Ekpo P., Sarasombath S., Banchuin N., Pongsunk S., Korbsrisate S., and Sirisinha S. Monoclonal antibody against protein antigens of Salmonella causing paratyphoid fever and their diagnostic application. Asian Pac J Allergy Immunol 13 1 (1995) 63-70
17. Parkhill J., Dougan G., James K.D., Thomson N.R., Pickard D., Wain J., et al. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413 6858 (2001) 848-852
18. McClelland M., Sanderson K.E., Spieth J., Clifton S.W., Latreille P., Courtney L., et al. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413 6858 (2001) 852-856
19. Sanderson K.E., Hessel A., and Rudd K.E. Genetic map of Salmonella typhimurium, edition VIII. Microbiol Rev 59 2 (1995) 241-303
20. Boyd E.F., Li J., Ochman H., and Selander R.K. Comparative genetics of the inv-spa invasion gene complex of Salmonella enterica. J Bacteriol 179 6 (1997) 1985-1991
21. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning a laboratory manual (1989), Cold Spring Harbor Laboratory Press, New York 1.21-1.52, 2.60-2.80, 7.30-7.35, 9.14-9.22
22. Lewis S.M., and Osei-Bimpong A. Haemoglobinometry in general practice. Clin Lab Haematol 25 6 (2003) 343-346
23. Levesque P.M., Foster K., and de Alwis U. Association between immunogenicity and adsorption of a recombinant Streptococcus pneumomiae vaccine antigen by aluminum adjuvant. Human Vaccines 2 2 (2006) 74-77
24. Xia X.P., Yan J., Zhao S.F., Mao Y.-F., and Li S.-P. Cloning, expression and identification of Escherichia coli LTB gene and Vibrio cholerae CTB gene. J Zhejiang Univ Med Sci 32 1 (2003) 17-20
25. Muthukkumar S., and Muthukkaruppan V.R. Mechanism of protective immunity induced by porin-lipopolysaccharide against murine salmonellosis. Infect Immun 61 7 (1993) 3017-3025
26. Ortiz V., Isibasi A., Garcia-Ortigoza E., and Kumate J. Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever. J Clin Microbiol 27 7 (1989) 1640-1645
27. Tabaraie B., Sharma B.K., Sharma P.R., Sehgal R., and Ganguly N.K. Evaluation of Salmonella porins as a broad spectrum vaccine candidate. Microbiol Immunol 38 7 (1994) 553-559
28. Singh S.P., Singh S.R., Williams Y.U., Jones L., and Abdullah T. Antigenic determinants of the OmpC porin from Salmonella typhimurium. Infect Immun 63 12 (1995) 4600-4605
29. Frankel G., Newton S.M., Schoolnik G.K., and Stocker B.A. Intragenic recombination in a flagellin gene: characterization of the H1-j gene of Salmonella typhi. EMBO J 10 8 (1989) 3149-3152
30. Echeita M.A., and Usera M.A. Rapid identification of Salmonella spp. Phase 2 antigens of the H1 antigenic complex using "multiplex PCR". Res Microbiol 149 10 (1998) 757-761
31. Echeita M.A., Herrera S., Garaizar J., and Usera M.A. Multiplex PCR-based detection and identification of the most common Salmonella second-phase flagellar antigens. Res Microbiol 153 2 (2002) 107-113
32. Mortimer C.K., Peters T.M., Gharbia S.E., Logan J.M., and Arnold C. Towards the development of a DNA-sequence based approach to serotyping of Salmonella enterica. BMC Microbiol 4 (2004) 31-41
33. Lau S.K., Woo P.C., Chan C.Y., Woo W.L., Woo G.K., and Yuen K.Y. Typhoid fever associated with acute appendicitis caused by an H1-j strain of Salmonella enterica serotype Typhi. J Clin Microbiol 43 3 (2005) 1470-1472
34. McSorley S.J., Cookson B.T., and Jenkins M.K. Characterization of CD4+ cell responses during natural infection with Salmonella typhimurium. J Immunol 164 2 (2000) 986-993
35. Strindelius L., Filler M., and Sjoholm I. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice. Vaccine 22 27-28 (2004) 3797-3808
36. Atkins H.S., Morton M., Griffin K.F., Stokes M.G., Nataro J.P., and Titball R.W. Recombinant Salmonella vaccines for biodefence. Vaccine 24 15 (2006) 2710-2717
37. Verweij W.R., De Haan L., Holtrop M., Agsteribbe E., Brands R., Van Scharrenburg G.J., et al. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen. Vaccine 16 20 (1998) 2069-2076
38. Pizza M., Giuliani M.M., Fontana M.R., Monaci E., Douce G., Dougan G., et al. Mucosal vaccines: non-toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19 17-19 (2001) 2534-2541
39. de Haan L., Verweij W.R., Holtrop M., Brands R., van Scharrenburg G.J.M., Palache A.M., et al. Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA or IgG-mediated protective mucosal immunity. Vaccine 19 20-22 (2001) 2898-2907